The content of complex psychedelic experiences resulting from inhalation of N,N-dimethyltryptamine
Stephen Kagan
Journal of Psychedelic Studies January 16, 2023 DOI: 10.1556/2054.2022.00209 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Population | People who smoked N,N-dimethyltryptamine and posted narrative accounts online |
| Interventions | smoking N N-dimethyltryptamine |
| Topics | 5-MeO-DMT DMT |
| Citations | 5 |
| Key findings | DMT experiences commonly described as indescribable and occurring in a single domain called Hyperspace actually contain distinct subcategories of frequently visited Places, encountered Entities, Objects, and Feelings. |
Abstract
AbstractAimThis study examines narratives describing complex psychedelic experiences after smoking N,N-dimethyltryptamine.MethodsThe narrative accounts examined here were gathered from a variety of online sites and analyzed in order to discover themes, categories and patterns in the phenomenon of the resulting psychedelic experiences.ResultsSubjects reported seeing complex and unusual visual and synesthetic phenomena, leaving this world and entering into extraordinary places, encounters with a variety of strange entities, interactions with unusual objects and a wide variety of powerful feelings. The general categories of Places, Objects, Entities and Feelings were found in the phenomena experienced by people who smoked N,N-Dimethyltryptamine. These provided a framework within which more detailed subcategories were found and the range of most frequent to least frequent experiences were identified.DiscussionWhile DMT experiences are commonly described by people smoking N,N-dimethyltryptamine as indescribable, unique to everyone and taking place in a single domain called Hyperspace or the Hyperdimension, this research found distinct subcategories of frequently visited Places as well as frequently encountered Entities, Objects and Feelings. From these a more comprehensive understanding can be developed of the unusual and profound experiences resulting from inhalation of N,N,-Dimethyltryptamine.
Comparable studies
Other qualitative studies on 5-MeO-DMT, most cited first.
Citations in the library
Cited by 5
- Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression. Neuropsychopharmacology May 1, 2025
- Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial. European Neuropsychopharmacology March 1, 2024
- Entity and environment relationships in psychedelic experiences resulting from inhalation of N,N-dimethyltryptamine Journal of Psychedelic Studies September 8, 2025
- Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency. Journal of Psychoactive Drugs October 15, 2024
- Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders Pharmacotherapy in Psychiatry and Neurology 2023
Cites 3
- Neural correlates of the DMT experience assessed with multivariate EEG. Scientific Reports November 19, 2019
- Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology September 1, 2020
- Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Archives of General Psychiatry February 1, 1994